Structure

Physi-Chem Properties

Molecular Weight:  302.08
Volume:  293.909
LogP:  1.912
LogD:  1.873
LogS:  -3.312
# Rotatable Bonds:  2
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.782
Synthetic Accessibility Score:  3.202
Fsp3:  0.188
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.398
MDCK Permeability:  9.838501682679635e-06
Pgp-inhibitor:  0.303
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.016

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.146
Plasma Protein Binding (PPB):  97.5795669555664%
Volume Distribution (VD):  0.565
Pgp-substrate:  4.011000156402588%

ADMET: Metabolism

CYP1A2-inhibitor:  0.206
CYP1A2-substrate:  0.331
CYP2C19-inhibitor:  0.127
CYP2C19-substrate:  0.377
CYP2C9-inhibitor:  0.325
CYP2C9-substrate:  0.785
CYP2D6-inhibitor:  0.524
CYP2D6-substrate:  0.289
CYP3A4-inhibitor:  0.407
CYP3A4-substrate:  0.248

ADMET: Excretion

Clearance (CL):  2.262
Half-life (T1/2):  0.404

ADMET: Toxicity

hERG Blockers:  0.066
Human Hepatotoxicity (H-HT):  0.049
Drug-inuced Liver Injury (DILI):  0.942
AMES Toxicity:  0.176
Rat Oral Acute Toxicity:  0.138
Maximum Recommended Daily Dose:  0.012
Skin Sensitization:  0.521
Carcinogencity:  0.188
Eye Corrosion:  0.003
Eye Irritation:  0.238
Respiratory Toxicity:  0.109

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC263449

Natural Product ID:  NPC263449
Common Name*:   Alnustinol
IUPAC Name:   (2R,3R)-3,5,7-trihydroxy-6-methoxy-2-phenyl-2,3-dihydrochromen-4-one
Synonyms:   Alnustinol
Standard InCHIKey:  HFDPLPWGKGPTJB-LSDHHAIUSA-N
Standard InCHI:  InChI=1S/C16H14O6/c1-21-16-9(17)7-10-11(13(16)19)12(18)14(20)15(22-10)8-5-3-2-4-6-8/h2-7,14-15,17,19-20H,1H3/t14-,15+/m0/s1
SMILES:  COc1c(O)cc2c(c1O)C(=O)[C@@H]([C@H](O2)c1ccccc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL252704
PubChem CID:   44446838
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002591] 6-O-methylated flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. Brazilian n.a. PMID[17950610]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. Brazilian n.a. PMID[18440233]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. n.a. n.a. PMID[26938776]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. n.a. n.a. PMID[32525315]
NPO8300 Apis mellifera ligustica Species Apidae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT461 Cell Line PANC-1 Homo sapiens CD100 > 100.0 uM PMID[545621]
NPT81 Cell Line A549 Homo sapiens IC50 > 100000.0 nM PMID[545622]
NPT165 Cell Line HeLa Homo sapiens IC50 > 100000.0 nM PMID[545622]
NPT453 Cell Line HT-1080 Homo sapiens IC50 > 100000.0 nM PMID[545622]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[545622]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC263449 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC308992
0.9801 High Similarity NPC320825
0.9801 High Similarity NPC326037
0.9801 High Similarity NPC255106
0.9801 High Similarity NPC201837
0.9801 High Similarity NPC235165
0.9801 High Similarity NPC13858
0.9737 High Similarity NPC210084
0.9737 High Similarity NPC48208
0.9737 High Similarity NPC99597
0.9737 High Similarity NPC474836
0.9737 High Similarity NPC162869
0.9737 High Similarity NPC52530
0.9737 High Similarity NPC156057
0.9737 High Similarity NPC474208
0.9737 High Similarity NPC475267
0.9673 High Similarity NPC152904
0.9671 High Similarity NPC250922
0.9615 High Similarity NPC224280
0.961 High Similarity NPC282009
0.961 High Similarity NPC287328
0.9608 High Similarity NPC471479
0.9608 High Similarity NPC471515
0.9608 High Similarity NPC470402
0.9608 High Similarity NPC245758
0.9608 High Similarity NPC472913
0.9608 High Similarity NPC96167
0.9608 High Similarity NPC472911
0.9608 High Similarity NPC472910
0.9608 High Similarity NPC222814
0.9608 High Similarity NPC472914
0.9605 High Similarity NPC201451
0.9605 High Similarity NPC26227
0.9605 High Similarity NPC37392
0.9605 High Similarity NPC44079
0.9605 High Similarity NPC2928
0.9603 High Similarity NPC61506
0.9603 High Similarity NPC120537
0.9603 High Similarity NPC36835
0.9603 High Similarity NPC240476
0.9603 High Similarity NPC199100
0.9603 High Similarity NPC219582
0.9603 High Similarity NPC180234
0.9603 High Similarity NPC260491
0.9603 High Similarity NPC302950
0.9603 High Similarity NPC246162
0.9603 High Similarity NPC236637
0.9603 High Similarity NPC9743
0.9548 High Similarity NPC471499
0.9548 High Similarity NPC173137
0.9545 High Similarity NPC250214
0.9545 High Similarity NPC55738
0.9545 High Similarity NPC95936
0.9545 High Similarity NPC22192
0.9542 High Similarity NPC303255
0.9542 High Similarity NPC266960
0.9542 High Similarity NPC49824
0.9542 High Similarity NPC247017
0.9542 High Similarity NPC98661
0.9542 High Similarity NPC43243
0.9542 High Similarity NPC471500
0.9542 High Similarity NPC474638
0.9542 High Similarity NPC472916
0.9542 High Similarity NPC245546
0.9539 High Similarity NPC325028
0.9539 High Similarity NPC246328
0.9539 High Similarity NPC206238
0.9539 High Similarity NPC292214
0.9539 High Similarity NPC88645
0.9539 High Similarity NPC271779
0.9539 High Similarity NPC256346
0.9539 High Similarity NPC167091
0.9539 High Similarity NPC18727
0.9539 High Similarity NPC27532
0.9536 High Similarity NPC204515
0.9536 High Similarity NPC117579
0.9494 High Similarity NPC42892
0.9494 High Similarity NPC295082
0.949 High Similarity NPC234052
0.949 High Similarity NPC470457
0.9484 High Similarity NPC470326
0.9484 High Similarity NPC470183
0.9481 High Similarity NPC472598
0.9481 High Similarity NPC227192
0.9481 High Similarity NPC203891
0.9481 High Similarity NPC189179
0.9481 High Similarity NPC101830
0.9481 High Similarity NPC93376
0.9481 High Similarity NPC223787
0.9481 High Similarity NPC78225
0.9481 High Similarity NPC75215
0.9481 High Similarity NPC474055
0.9481 High Similarity NPC469584
0.9481 High Similarity NPC305663
0.9481 High Similarity NPC287979
0.9481 High Similarity NPC110070
0.9481 High Similarity NPC176665
0.9481 High Similarity NPC224137
0.9481 High Similarity NPC67876
0.9481 High Similarity NPC163524
0.9477 High Similarity NPC472909
0.9477 High Similarity NPC213622
0.9474 High Similarity NPC120163
0.9474 High Similarity NPC101996
0.9474 High Similarity NPC275836
0.9474 High Similarity NPC301323
0.9474 High Similarity NPC198826
0.9474 High Similarity NPC293183
0.9474 High Similarity NPC25270
0.9474 High Similarity NPC162313
0.9474 High Similarity NPC212678
0.9474 High Similarity NPC39007
0.9474 High Similarity NPC131624
0.9474 High Similarity NPC83508
0.9474 High Similarity NPC239128
0.9474 High Similarity NPC222830
0.9474 High Similarity NPC156222
0.9474 High Similarity NPC256283
0.9474 High Similarity NPC187498
0.9474 High Similarity NPC57030
0.9474 High Similarity NPC71334
0.9474 High Similarity NPC301123
0.9474 High Similarity NPC161277
0.9474 High Similarity NPC241498
0.9474 High Similarity NPC188203
0.9474 High Similarity NPC100887
0.9474 High Similarity NPC275722
0.9474 High Similarity NPC19721
0.947 High Similarity NPC62042
0.947 High Similarity NPC61620
0.9427 High Similarity NPC41301
0.9427 High Similarity NPC470459
0.9427 High Similarity NPC472625
0.9423 High Similarity NPC266314
0.9419 High Similarity NPC143828
0.9419 High Similarity NPC288669
0.9419 High Similarity NPC25495
0.9419 High Similarity NPC22472
0.9419 High Similarity NPC204854
0.9419 High Similarity NPC115798
0.9419 High Similarity NPC253634
0.9419 High Similarity NPC18772
0.9419 High Similarity NPC130894
0.9419 High Similarity NPC4481
0.9419 High Similarity NPC191459
0.9419 High Similarity NPC18607
0.9419 High Similarity NPC7846
0.9419 High Similarity NPC300943
0.9419 High Similarity NPC105242
0.9419 High Similarity NPC19687
0.9419 High Similarity NPC176300
0.9419 High Similarity NPC261004
0.9419 High Similarity NPC329091
0.9419 High Similarity NPC9609
0.9419 High Similarity NPC152166
0.9416 High Similarity NPC474520
0.9416 High Similarity NPC191146
0.9416 High Similarity NPC195796
0.9416 High Similarity NPC291878
0.9416 High Similarity NPC68093
0.9416 High Similarity NPC35038
0.9416 High Similarity NPC292107
0.9416 High Similarity NPC278778
0.9412 High Similarity NPC69394
0.9412 High Similarity NPC183878
0.9412 High Similarity NPC145379
0.9412 High Similarity NPC472915
0.9412 High Similarity NPC255350
0.9412 High Similarity NPC86485
0.9412 High Similarity NPC274327
0.9412 High Similarity NPC47781
0.9412 High Similarity NPC22519
0.9412 High Similarity NPC176775
0.9412 High Similarity NPC160951
0.9412 High Similarity NPC231018
0.9412 High Similarity NPC141212
0.9408 High Similarity NPC252933
0.9408 High Similarity NPC171010
0.9408 High Similarity NPC54394
0.9408 High Similarity NPC225731
0.9408 High Similarity NPC149614
0.9408 High Similarity NPC251110
0.9408 High Similarity NPC200740
0.9408 High Similarity NPC125062
0.9408 High Similarity NPC31363
0.9371 High Similarity NPC243877
0.9371 High Similarity NPC470456
0.9371 High Similarity NPC158761
0.9371 High Similarity NPC14662
0.9367 High Similarity NPC36
0.9367 High Similarity NPC7688
0.9367 High Similarity NPC125039
0.9367 High Similarity NPC58223
0.9367 High Similarity NPC7154
0.9367 High Similarity NPC72787
0.9367 High Similarity NPC62261
0.9367 High Similarity NPC36916
0.9359 High Similarity NPC471744
0.9359 High Similarity NPC246478
0.9355 High Similarity NPC181960

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC263449 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9603 High Similarity NPD1934 Approved
0.9412 High Similarity NPD2801 Approved
0.9367 High Similarity NPD6166 Phase 2
0.9367 High Similarity NPD6168 Clinical (unspecified phase)
0.9367 High Similarity NPD6167 Clinical (unspecified phase)
0.9286 High Similarity NPD2393 Clinical (unspecified phase)
0.9167 High Similarity NPD3882 Suspended
0.9085 High Similarity NPD4338 Clinical (unspecified phase)
0.9079 High Similarity NPD1512 Approved
0.8947 High Similarity NPD1511 Approved
0.8902 High Similarity NPD7074 Phase 3
0.8896 High Similarity NPD3818 Discontinued
0.8861 High Similarity NPD3817 Phase 2
0.8848 High Similarity NPD6797 Phase 2
0.8841 High Similarity NPD7054 Approved
0.8795 High Similarity NPD7251 Discontinued
0.8788 High Similarity NPD7472 Approved
0.8758 High Similarity NPD5494 Approved
0.8743 High Similarity NPD7808 Phase 3
0.8688 High Similarity NPD4868 Clinical (unspecified phase)
0.8675 High Similarity NPD1552 Clinical (unspecified phase)
0.8675 High Similarity NPD1550 Clinical (unspecified phase)
0.8645 High Similarity NPD4378 Clinical (unspecified phase)
0.8634 High Similarity NPD7075 Discontinued
0.8618 High Similarity NPD1549 Phase 2
0.8608 High Similarity NPD4380 Phase 2
0.8562 High Similarity NPD7096 Clinical (unspecified phase)
0.8519 High Similarity NPD4381 Clinical (unspecified phase)
0.8512 High Similarity NPD7993 Clinical (unspecified phase)
0.8509 High Similarity NPD5402 Approved
0.8393 Intermediate Similarity NPD5844 Phase 1
0.8393 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD6801 Discontinued
0.8364 Intermediate Similarity NPD1247 Approved
0.8344 Intermediate Similarity NPD6799 Approved
0.8301 Intermediate Similarity NPD1510 Phase 2
0.8278 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD1613 Approved
0.8247 Intermediate Similarity NPD2796 Approved
0.8221 Intermediate Similarity NPD1465 Phase 2
0.8204 Intermediate Similarity NPD6232 Discontinued
0.8171 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD7473 Discontinued
0.8158 Intermediate Similarity NPD1240 Approved
0.8158 Intermediate Similarity NPD943 Approved
0.8148 Intermediate Similarity NPD6599 Discontinued
0.811 Intermediate Similarity NPD7819 Suspended
0.8075 Intermediate Similarity NPD5403 Approved
0.8063 Intermediate Similarity NPD5401 Approved
0.8052 Intermediate Similarity NPD1607 Approved
0.8047 Intermediate Similarity NPD3926 Phase 2
0.8036 Intermediate Similarity NPD6959 Discontinued
0.8035 Intermediate Similarity NPD6559 Discontinued
0.8024 Intermediate Similarity NPD919 Approved
0.8013 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD3751 Discontinued
0.7988 Intermediate Similarity NPD7411 Suspended
0.7961 Intermediate Similarity NPD3027 Phase 3
0.795 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD3787 Discontinued
0.7875 Intermediate Similarity NPD6190 Approved
0.7871 Intermediate Similarity NPD230 Phase 1
0.7834 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD1653 Approved
0.7799 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD2935 Discontinued
0.7756 Intermediate Similarity NPD447 Suspended
0.7753 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD3749 Approved
0.775 Intermediate Similarity NPD2800 Approved
0.7722 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD3750 Approved
0.7702 Intermediate Similarity NPD4628 Phase 3
0.7688 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD1551 Phase 2
0.7636 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD2533 Approved
0.7622 Intermediate Similarity NPD2534 Approved
0.7622 Intermediate Similarity NPD2532 Approved
0.7616 Intermediate Similarity NPD7199 Phase 2
0.7602 Intermediate Similarity NPD6234 Discontinued
0.7597 Intermediate Similarity NPD9494 Approved
0.7593 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD7768 Phase 2
0.7564 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD6777 Approved
0.754 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD6780 Approved
0.754 Intermediate Similarity NPD6782 Approved
0.754 Intermediate Similarity NPD6776 Approved
0.754 Intermediate Similarity NPD6779 Approved
0.754 Intermediate Similarity NPD6781 Approved
0.754 Intermediate Similarity NPD6778 Approved
0.7532 Intermediate Similarity NPD1933 Approved
0.7531 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD920 Approved
0.7516 Intermediate Similarity NPD2344 Approved
0.7515 Intermediate Similarity NPD37 Approved
0.7514 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD7228 Approved
0.7485 Intermediate Similarity NPD4965 Approved
0.7485 Intermediate Similarity NPD4966 Approved
0.7485 Intermediate Similarity NPD4967 Phase 2
0.7455 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD6100 Approved
0.7453 Intermediate Similarity NPD6099 Approved
0.744 Intermediate Similarity NPD3226 Approved
0.7434 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD7685 Pre-registration
0.7421 Intermediate Similarity NPD7435 Discontinued
0.7418 Intermediate Similarity NPD8150 Discontinued
0.7412 Intermediate Similarity NPD6844 Discontinued
0.741 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2346 Discontinued
0.7405 Intermediate Similarity NPD6233 Phase 2
0.7391 Intermediate Similarity NPD3748 Approved
0.7391 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD5953 Discontinued
0.736 Intermediate Similarity NPD7286 Phase 2
0.7348 Intermediate Similarity NPD8312 Approved
0.7348 Intermediate Similarity NPD8313 Approved
0.7342 Intermediate Similarity NPD2313 Discontinued
0.7342 Intermediate Similarity NPD6798 Discontinued
0.7338 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2309 Approved
0.733 Intermediate Similarity NPD7697 Approved
0.733 Intermediate Similarity NPD7696 Phase 3
0.733 Intermediate Similarity NPD7698 Approved
0.7325 Intermediate Similarity NPD4908 Phase 1
0.732 Intermediate Similarity NPD1610 Phase 2
0.7317 Intermediate Similarity NPD1243 Approved
0.7305 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD7871 Phase 2
0.7292 Intermediate Similarity NPD7870 Phase 2
0.7289 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD2799 Discontinued
0.7284 Intermediate Similarity NPD7033 Discontinued
0.7273 Intermediate Similarity NPD6535 Approved
0.7273 Intermediate Similarity NPD6534 Approved
0.7273 Intermediate Similarity NPD4360 Phase 2
0.7273 Intermediate Similarity NPD4363 Phase 3
0.7268 Intermediate Similarity NPD7701 Phase 2
0.7267 Intermediate Similarity NPD6651 Approved
0.7261 Intermediate Similarity NPD2861 Phase 2
0.7244 Intermediate Similarity NPD1203 Approved
0.7233 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD5242 Approved
0.7225 Intermediate Similarity NPD5353 Approved
0.7205 Intermediate Similarity NPD6355 Discontinued
0.7205 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD7874 Approved
0.7194 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD2403 Approved
0.7175 Intermediate Similarity NPD5711 Approved
0.7175 Intermediate Similarity NPD5710 Approved
0.7171 Intermediate Similarity NPD1548 Phase 1
0.7169 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD9269 Phase 2
0.7158 Intermediate Similarity NPD7699 Phase 2
0.7158 Intermediate Similarity NPD7700 Phase 2
0.7157 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD7783 Phase 2
0.7157 Intermediate Similarity NPD7801 Approved
0.7152 Intermediate Similarity NPD2424 Discontinued
0.7151 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7390 Discontinued
0.7143 Intermediate Similarity NPD8151 Discontinued
0.7128 Intermediate Similarity NPD7584 Approved
0.7111 Intermediate Similarity NPD2163 Approved
0.7108 Intermediate Similarity NPD1652 Phase 2
0.7107 Intermediate Similarity NPD6832 Phase 2
0.7101 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7098 Intermediate Similarity NPD6823 Phase 2
0.7091 Intermediate Similarity NPD7266 Discontinued
0.7079 Intermediate Similarity NPD4111 Phase 1
0.7079 Intermediate Similarity NPD4665 Approved
0.7052 Intermediate Similarity NPD6385 Approved
0.7052 Intermediate Similarity NPD6386 Approved
0.7051 Intermediate Similarity NPD9717 Approved
0.7051 Intermediate Similarity NPD1608 Approved
0.7049 Intermediate Similarity NPD7240 Approved
0.7047 Intermediate Similarity NPD2494 Approved
0.7047 Intermediate Similarity NPD2493 Approved
0.7037 Intermediate Similarity NPD4060 Phase 1
0.7035 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD2354 Approved
0.7019 Intermediate Similarity NPD3268 Approved
0.7011 Intermediate Similarity NPD7549 Discontinued
0.701 Intermediate Similarity NPD7907 Approved
0.7 Intermediate Similarity NPD4661 Approved
0.7 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4662 Approved
0.6995 Remote Similarity NPD2899 Discontinued
0.6994 Remote Similarity NPD5124 Phase 1
0.6994 Remote Similarity NPD5123 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data